Maria D. Carrion

Granada, AN 18016, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Benzoxazine-Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action.

Benzoxazine-Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action.

Journal: Pharmaceutics

Published: September 03, 2025

CD44-targeted N-benzyltetrahydroisoquinoline derivatives as anticancer agents with high tumor-to-normal cell selectivity.

CD44-targeted N-benzyltetrahydroisoquinoline derivatives as anticancer agents with high tumor-to-normal cell selectivity.

Journal: European journal of medicinal chemistry

Published: June 11, 2025

New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death.

New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death.

Journal: Bioorganic & medicinal chemistry

Published: June 20, 2024

New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer.

New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer.

Journal: European journal of medicinal chemistry

Published: November 21, 2022

NMR spectroscopy study of new imidamide derivatives as nitric oxide synthase inhibitors.

NMR spectroscopy study of new imidamide derivatives as nitric oxide synthase inhibitors.

Journal: Magnetic resonance in chemistry : MRC

Published: March 03, 2022

Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.

Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: May 11, 2021

NMR studies of new heterocycles tethered to purine moieties with anticancer activity.

NMR studies of new heterocycles tethered to purine moieties with anticancer activity.

Journal: Magnetic resonance in chemistry : MRC

Published: January 23, 2019

Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.

Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.

Journal: Future medicinal chemistry

Published: January 16, 2019

Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.

Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.

Journal: Archiv der Pharmazie

Published: January 22, 2016

(1) H and (13) C NMR spectral assignment of N,N'-disubstituted thiourea and urea derivatives active against nitric oxide synthase.

(1) H and (13) C NMR spectral assignment of N,N'-disubstituted thiourea and urea derivatives active against nitric oxide synthase.

Journal: Magnetic resonance in chemistry : MRC

Published: January 11, 2016

NMR assignments and structural characterization of new thiourea and urea kynurenamine derivatives nitric oxide synthase inhibitors.

NMR assignments and structural characterization of new thiourea and urea kynurenamine derivatives nitric oxide synthase inhibitors.

Journal: Magnetic resonance in chemistry : MRC

Published: May 11, 2015

Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.

Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.

Journal: ChemMedChem

Published: January 09, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026